Drug intelligence / Profile preview

magnesium alginate

Development stage
Unknown
Lead developer
Aurora Biofarma
Modality
Small Molecules, Hydrogel Systems → Drug Delivery Systems
Administration
Oral, Ophthalmic
01

Overview

Magnesium alginate is a polysaccharide salt derived from alginic acid, which is extracted from brown seaweed (algae). It functions primarily as an anti-reflux agent and mucosal protectant. Upon contact with gastric acid, magnesium alginate reacts to form a low-density, pH-neutral viscous gel, commonly referred to as a "raft," that floats on top of the stomach contents. This raft acts as a physical, mechanical barrier to prevent the reflux of acid, pepsin, and bile into the esophagus and larynx. Beyond its antireflux properties, magnesium alginate exhibits mucoadhesive characteristics, forming a protective film over the esophageal and pharyngeal mucosa to protect against chemical injury and promote tissue regeneration. It is widely used in the management of **gastroesophageal reflux disease (GERD)** and **laryngopharyngeal reflux (LPR)**, and is frequently employed in pediatric populations for infant regurgitation due to its non-systemic safety profile. It is often regulated as a Class IIa medical device in the European Union and may be formulated as oral suspensions, tablets, or topical ophthalmic drops.

Other names
magnesium salt of alginic acidMg alginate
02

Targets

PEP (Pepsin)

Beyond the preview

Go deeper on magnesium alginate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium alginate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call